EGFR and neoplasm: To identify this resistance mechanism we isolated and clonally expanded tumor cell isolates that gained the ability to grow despite inhibition of oncogenic signaling mediated by epidermal growth factor (EGFR/HER2) and downstream protein kinase (MAPK or AKT) signaling.